X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (735) 735
Publication (110) 110
Book Chapter (6) 6
Conference Proceeding (6) 6
Patent (6) 6
Book Review (4) 4
Book / eBook (1) 1
Magazine Article (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (390) 390
female (265) 265
index medicus (225) 225
male (148) 148
adult (138) 138
middle aged (109) 109
hematology (107) 107
pregnancy (107) 107
aged (104) 104
risk factors (94) 94
obstetrics & gynecology (77) 77
peripheral vascular disease (74) 74
immunology (56) 56
prospective studies (55) 55
recurrence (50) 50
risk (50) 50
animals (48) 48
anticoagulants (48) 48
thromboembolism (47) 47
aged, 80 and over (45) 45
diagnosis (45) 45
venous thromboembolism (45) 45
medicine, general & internal (42) 42
cardiac & cardiovascular systems (41) 41
infant, newborn (41) 41
therapy (41) 41
adolescent (40) 40
treatment outcome (39) 39
anticoagulants - therapeutic use (38) 38
abridged index medicus (35) 35
time factors (34) 34
anticoagulants - administration & dosage (32) 32
mortality (32) 32
pulmonary-embolism (32) 32
follow-up studies (31) 31
predictive value of tests (31) 31
analysis (30) 30
care and treatment (30) 30
gestational age (30) 30
thrombosis (30) 30
cells, cultured (29) 29
d-dimer (29) 29
double-blind method (29) 29
lymphocytes (29) 29
warfarin (28) 28
atrial fibrillation (27) 27
deep-vein thrombosis (27) 27
disease (26) 26
drug therapy (26) 26
prevention (26) 26
health aspects (24) 24
hematology, oncology and palliative medicine (24) 24
stroke (24) 24
case-control studies (23) 23
cytokines (23) 23
expression (23) 23
ultrasonography, prenatal (23) 23
young adult (23) 23
management (22) 22
venous thrombosis (22) 22
venous thrombosis - drug therapy (22) 22
administration, oral (21) 21
cardiovascular disease (21) 21
risk assessment (21) 21
th1 cells - immunology (21) 21
ultrasonography (21) 21
venous thrombosis - blood (21) 21
women (21) 21
anticoagulants - adverse effects (20) 20
anticoagulation (20) 20
cardiovascular diseases (20) 20
inflammation (20) 20
reproductive biology (20) 20
allergy (19) 19
heart failure (19) 19
infants (19) 19
research (19) 19
t cells (19) 19
children (18) 18
deep vein thrombosis (18) 18
double-blind (18) 18
italy (18) 18
medical research (18) 18
sensitivity and specificity (18) 18
venous thromboembolism - blood (18) 18
vitamin k - antagonists & inhibitors (18) 18
fibrin fibrinogen degradation products - analysis (17) 17
health risk assessment (17) 17
phenotype (17) 17
pregnancy outcome (17) 17
surgery (17) 17
clinical trials (16) 16
cohort studies (16) 16
dose-response relationship, drug (16) 16
medicine (16) 16
pediatrics (16) 16
physiological aspects (16) 16
reproducibility of results (16) 16
child (15) 15
dendritic cells (15) 15
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2017, Volume 376, Issue 18, pp. 1713 - 1722
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article